|
Volumn 18, Issue 1, 2004, Pages 131-
|
Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
CD4 ANTIGEN;
INSULIN;
LAMIVUDINE;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
STAVUDINE;
STEROID;
ZIDOVUDINE;
ADULT;
ANEMIA;
BLOOD TOXICITY;
CASE REPORT;
CHRONIC HEPATITIS;
COMORBIDITY;
DIABETES MELLITUS;
DRUG EFFICACY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HEMOLYTIC ANEMIA;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LONG TERM CARE;
LUNG ASPERGILLOSIS;
MALE;
NEUTROPENIA;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
T LYMPHOCYTE SUBPOPULATION;
THROMBOCYTOPENIA;
|
EID: 1642505816
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200401020-00018 Document Type: Letter |
Times cited : (3)
|
References (6)
|